Skip to main content

Table 2 Summary of mean and standard deviation (SD) for haemoglobin (Hb) and haematinics; serum ferritin and transferrin saturation (TSAT) at baseline, 1 and 3 months

From: A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status

   FDI Placebo  
  Mean SD n Mean SD n P value
Hb Baseline 131.0 7.4 26 126.5 11.8 28  
1 month 132.7 7.2 24 125.5 12.8 26 0.195
3 months 134.7 8.9 20 126.2 12.4 25 0.152
Serum Ferritin Baseline 64.2 29.1 26 68.4 55.3 27  
1 month 266.0 105.8 23 70.5 55.8 26 < 0.001
3 months 234.4 105.3 21 69.4 59.8 24 < 0.001
TSAT Baseline 22.3 8.8 26 19.7 5.6 27  
1 month 29.6 9.5 22 19.1 7.1 26 < 0.001
3 months 26.4 10.5 21 18.0 6.8 23 < 0.001
  1. There was a statistically significant difference for SF and TSAT at both 1-month (p < 0.001, p < 0.001) and 3 (p < 0.001 and p = 0.001) months, respectively, with greater increases in the FDI group (Figs. 3 and 4, Table 2)